Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cfi-402257
1. Cfi-402257
2. 1610759-22-2
3. He97ptk3q6
4. Cid 118086034
5. Chembl4442392
6. Chembl4469414
7. Cfi402257
8. Cfi 402257
9. Benzamide, N-cyclopropyl-4-(7-(((cis-3-hydroxy-3-methylcyclobutyl)methyl)amino)-5-(3-pyridinyloxy)pyrazolo(1,5-a)pyrimidin-3-yl)-2-methyl-
10. N-cyclopropyl-4-(7-(((cis-3-hydroxy-3-methylcyclobutyl)methyl)amino)-5-(3-pyridinyloxy)pyrazolo(1,5-a)pyrimidin-3-yl)-2-methylbenzamide
11. Luvixasertib
12. Unii-he97ptk3q6
13. Schembl16729234
14. Schembl17182976
15. Schembl17190272
16. Schembl22046104
17. Schembl22875551
18. Gtpl11664
19. Bcp31204
20. Ex-a2577
21. Bdbm50512456
22. Bdbm50533120
23. Nsc800888
24. Zinc669678971
25. Cs-6527
26. Nsc-800888
27. Sb19839
28. Compound 24 [pmid: 27437075]
29. Ac-36155
30. Hy-101340
31. Cfi 402257; Cfi402257
32. J3.619.525h
33. A906482
34. 1610677-37-6
35. N-cyclopropyl-4-(7-((((1r,3r)-3-hydroxy-3-methylcyclobutyl)methyl)amino)-5-(pyridin-3-yloxy)pyrazolo[1,5-a]pyrimidin-3-yl)-2-methylbenzamide
36. N-cyclopropyl-4-[7-[[(cis-3-hydroxy-3-methylcyclobutyl)methyl]amino]-5-(3-pyridinyloxy)pyrazolo[1,5-a]pyrimidin-3-yl]-2-methyl-benzamide
| Molecular Weight | 498.6 g/mol |
|---|---|
| Molecular Formula | C28H30N6O3 |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 8 |
| Exact Mass | 498.23793884 g/mol |
| Monoisotopic Mass | 498.23793884 g/mol |
| Topological Polar Surface Area | 114 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 805 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
54
PharmaCompass offers a list of CFI-402257 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right CFI-402257 manufacturer or CFI-402257 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred CFI-402257 manufacturer or CFI-402257 supplier.
PharmaCompass also assists you with knowing the CFI-402257 API Price utilized in the formulation of products. CFI-402257 API Price is not always fixed or binding as the CFI-402257 Price is obtained through a variety of data sources. The CFI-402257 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CFI 402257 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CFI 402257, including repackagers and relabelers. The FDA regulates CFI 402257 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CFI 402257 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CFI 402257 supplier is an individual or a company that provides CFI 402257 active pharmaceutical ingredient (API) or CFI 402257 finished formulations upon request. The CFI 402257 suppliers may include CFI 402257 API manufacturers, exporters, distributors and traders.
CFI 402257 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CFI 402257 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CFI 402257 GMP manufacturer or CFI 402257 GMP API supplier for your needs.
A CFI 402257 CoA (Certificate of Analysis) is a formal document that attests to CFI 402257's compliance with CFI 402257 specifications and serves as a tool for batch-level quality control.
CFI 402257 CoA mostly includes findings from lab analyses of a specific batch. For each CFI 402257 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CFI 402257 may be tested according to a variety of international standards, such as European Pharmacopoeia (CFI 402257 EP), CFI 402257 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CFI 402257 USP).
